Stéphanie Kromar

Towards a more proportionate EU framework for low-intervention clinical trials: Lessons from the UK and Switzerland.

INTRODUCTION Post-marketing treatment-optimisation trials evaluate established therapies to determine their optimal dosage, duration, sequencing, scheduling, and use in combination strategies. Although these studies may qualify as low-intervention clinical trials and generally entail lower additional risks than pre-aut...